News
PFE
24.20
+1.13%
0.27
Healthcare sector flexes earnings muscle, but top-line cracks show
Seeking Alpha · 10h ago
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (May 2025)
Seeking Alpha · 20h ago
The Play On Legend Biotech
Seeking Alpha · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of May 4
Seeking Alpha · 1d ago
Catalyst Watch: Powell presser, AMD earnings, IBM event, and Lions Gate splits in two
Seeking Alpha · 1d ago
Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can't Figure Out How Much to Worry.
Barron‘s · 1d ago
Notable ETF Inflow Detected - XLV, TMO, PFE, GILD
NASDAQ · 1d ago
SA Charts: SPY maintains Q1 dividend growth by raising payout 7%
Seeking Alpha · 1d ago
Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon
Seeking Alpha · 1d ago
Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont
NASDAQ · 1d ago
Dividend Roundup: Apple, Coca-Cola, Exxon Mobil, Citigroup, and more
Seeking Alpha · 1d ago
Pre-Market Most Active for May 2, 2025 : KIDZ, TSLL, SQQQ, AMCR, NVDA, TQQQ, PFE, WMT, AMZN, XYZ, BBAI, FUBO
NASDAQ · 1d ago
Arvinas price target lowered to $16 from $32 at Guggenheim
TipRanks · 1d ago
Build Your Own ATM: 2 Undervalued Dividend Machines Yielding 7%
Seeking Alpha · 1d ago
Arvinas price target lowered to $19 from $26 at Wells Fargo
TipRanks · 1d ago
Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil
Barchart · 1d ago
3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May
The Motley Fool · 2d ago
The GLP-1 Saga Continues, And How
Seeking Alpha · 2d ago
Arvinas downgraded to Hold at Jefferies after Vepdeg development decision
TipRanks · 2d ago
Arvinas Shares Drop; Cancels Two Drug Trials With Pfizer Amid Capital Markets Challenges
Dow Jones · 2d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
More
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Recently
Symbol
Price
%Change